The estimated Net Worth of 1 Llc Alphaeon is at least $105 Milhão dollars as of 17 February 2023. 1 Alphaeon owns over 1,850,000 units of Evolus Inc stock worth over $64,361,080 and over the last 3 years 1 sold EOLS stock worth over $40,216,013.
1 has made over 2 trades of the Evolus Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently 1 sold 1,850,000 units of EOLS stock worth $15,540,000 on 17 February 2023.
The largest trade 1's ever made was selling 2,597,475 units of Evolus Inc stock on 2 September 2021 worth over $24,676,013. On average, 1 trades about 2,223,738 units every 267 days since 2021. As of 17 February 2023 1 still owns at least 4,214,871 units of Evolus Inc stock.
You can see the complete history of 1 Alphaeon stock trades at the bottom of the page.
1's mailing address filed with the SEC is 4040 MACARTHUR BOULEVARD, SUITE 310, , NEWPORT BEACH, CA, 92660.
Over the last 7 years, insiders at Evolus Inc have traded over $244,915,132 worth of Evolus Inc stock and bought 3,308,677 units worth $53,545,237 . The most active insiders traders include Biopharma, Inc. Aeon, Inc. Medytox, e1 Llc Alphaeon. On average, Evolus Inc executives and independent directors trade stock every 25 days with the average trade being worth of $3,606,270. The most recent stock trade was executed by Sandra Beaver on 6 September 2024, trading 3,276 units of EOLS stock currently worth $49,074.
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
Evolus Inc executives and other stock owners filed with the SEC include: